Bartlett & Co Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Bartlett & Co Wealth Management's BSX Position: Q2 2026 in Review
Bartlett & Co Wealth Management reduced its Boston Scientific (BSX) stake by 23% in Q2 2026, selling an estimated $16.6K and leaving 1,013 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #771.
Bartlett & Co Wealth Management first reported a position in BSX in Q1 2019 and has held it in 28 quarters since. The position peaked at $125K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Bartlett & Co Wealth Management held 1,013 shares of Boston Scientific worth $43.2K as of Q2 2026.
- Bartlett & Co Wealth Management sold 306 Boston Scientific shares in Q2 2026, an estimated $16.6K.
- Boston Scientific made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #771 holding.
- Bartlett & Co Wealth Management first reported a position in Boston Scientific in Q1 2019 and has held it in 28 quarters since.
- Bartlett & Co Wealth Management's Boston Scientific position peaked at $125K in Q4 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.